Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil

View ORCID ProfileCarlos A. Prete Jr, View ORCID ProfileLewis F. Buss, View ORCID ProfileClaudia M. M. Abrahim, View ORCID ProfileTassila Salomon, View ORCID ProfileMyuki A. E. Crispim, View ORCID ProfileMarcio K. Oikawa, View ORCID ProfileRenata Buccheri, View ORCID ProfileEduard Grebe, View ORCID ProfileAllyson G. da Costa, View ORCID ProfileNelson A. Fraiji, View ORCID ProfileMaria do P. S. S. Carvalho, View ORCID ProfileNeal Alexander, View ORCID ProfileNuno R. Faria, View ORCID ProfileChristopher Dye, View ORCID ProfileVítor H. Nascimento, View ORCID ProfileMichael P. Busch, View ORCID ProfileEster C. Sabino
doi: https://doi.org/10.1101/2021.05.10.21256644
Carlos A. Prete Jr
1Department of Electronic Systems Engineering, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos A. Prete Jr
Lewis F. Buss
2Departamento de Moléstias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lewis F. Buss
Claudia M. M. Abrahim
3Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudia M. M. Abrahim
Tassila Salomon
4Fundação Hemominas; Faculdade de Ciências Médicas de Minas Gerais, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tassila Salomon
Myuki A. E. Crispim
3Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Myuki A. E. Crispim
Marcio K. Oikawa
5Center of Mathematics, Computing and Cognition, Universidade Federal do ABC, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcio K. Oikawa
Renata Buccheri
6Vitalant Research Institute, San Francisco CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Renata Buccheri
Eduard Grebe
6Vitalant Research Institute, San Francisco CA, USA
7University of California San Francisco, San Francisco CA, USA
8SACEMA, Stellenbosch University, Stellenbosch, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduard Grebe
Allyson G. da Costa
3Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Allyson G. da Costa
Nelson A. Fraiji
3Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nelson A. Fraiji
Maria do P. S. S. Carvalho
3Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria do P. S. S. Carvalho
Neal Alexander
9Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Neal Alexander
Nuno R. Faria
2Departamento de Moléstias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
10MRC Centre for Global Infectious Disease Analysis; and the Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, UK
11Department of Zoology, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nuno R. Faria
Christopher Dye
11Department of Zoology, University of Oxford, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher Dye
Vítor H. Nascimento
1Department of Electronic Systems Engineering, University of São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vítor H. Nascimento
Michael P. Busch
6Vitalant Research Institute, San Francisco CA, USA
7University of California San Francisco, San Francisco CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael P. Busch
Ester C. Sabino
2Departamento de Moléstias Infecciosas e Parasitarias and Instituto de Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ester C. Sabino
  • For correspondence: sabinoec@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The city of Manaus, north Brazil, was stricken by a severe epidemic of SARS-Cov-2 in March 2020, reaching a seroprevalence of 76% by October 2020. Nevertheless, in late November an abrupt increase in hospitalizations and deaths hit Manaus, causing higher number of deaths compared to the first epidemic wave. It has been hypothesized that virus lineages circulating in the second wave, namely the P.1 variant of concern first detected in early December in Manaus, could be better at evading immunity generated in response to previous infection with other lineages.

In order to estimate the reinfection rate during the resurgence of SARS-CoV-2 in Manaus, we tested serial samples from 238 unvaccinated repeat blood donors using a SARS-CoV-2 anti-N IgG chemiluminescence microparticle assay. Blood donors were divided into six groups that reflected the inferred sequence of infection and reinfection with non-P.1 and P.1 variants. We assumed that reinfections induce a recrudescence (or “boosting”) of plasma anti-N IgG antibody levels, yielding a V-shaped time series of antibody reactivity levels.

We infer that 16.9% (95% CI [9.48%, 28.5%]) of all presumed P.1 infections that were observed in 2021 were reinfections. If we also include cases of probable or possible reinfections (defined by considering the time period when the antibody levels are expected to grow after recovery and the range of half-lives for antibody waning after seroconversion), these percentages increase respectively to 25.8% (95% CI [16.7%, 37.4%]), and 31.0% (95% CI [21.4%, 42.5%]). Our data suggest that reinfection due to P.1 is common and more frequent than what has been detected by traditional epidemiologic, molecular and genomic surveillance of clinical cases.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Itau Unibanco Todos pela Saude program and by a Medical Research Council-Sao Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) (caddecentre.org/). Wellcome Trust and Royal Society (N.R.F. Sir Henry Dale Fellowship: 204311/Z/16/Z); the National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS, now in its fourth phase, REDS-IV-P) for providing the blood donor demographic data for analysis (grant HHSN268201100007I). CAPJ was supported by FAPESP (2019/21858-0), Fundacao Faculdade de Medicina and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES), Finance Code 001. VHN was supported by CNPq (304714/2018-6).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This project was approved by the Brazilian national research ethics committee, CONEP CAAE - 397909020.9.1001.0009

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data can be shared upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil
Carlos A. Prete Jr, Lewis F. Buss, Claudia M. M. Abrahim, Tassila Salomon, Myuki A. E. Crispim, Marcio K. Oikawa, Renata Buccheri, Eduard Grebe, Allyson G. da Costa, Nelson A. Fraiji, Maria do P. S. S. Carvalho, Neal Alexander, Nuno R. Faria, Christopher Dye, Vítor H. Nascimento, Michael P. Busch, Ester C. Sabino
medRxiv 2021.05.10.21256644; doi: https://doi.org/10.1101/2021.05.10.21256644
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil
Carlos A. Prete Jr, Lewis F. Buss, Claudia M. M. Abrahim, Tassila Salomon, Myuki A. E. Crispim, Marcio K. Oikawa, Renata Buccheri, Eduard Grebe, Allyson G. da Costa, Nelson A. Fraiji, Maria do P. S. S. Carvalho, Neal Alexander, Nuno R. Faria, Christopher Dye, Vítor H. Nascimento, Michael P. Busch, Ester C. Sabino
medRxiv 2021.05.10.21256644; doi: https://doi.org/10.1101/2021.05.10.21256644

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (171)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8794)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (493)
  • Hematology (207)
  • HIV/AIDS (396)
  • Infectious Diseases (except HIV/AIDS) (10575)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1762)
  • Nursing (104)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (966)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3992)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)